Tag Archives: CHARM
August 2017 Br J Cardiol 2017;24:(3) Online First
BCS 2017: spotlight on heart failure
BJC Staff, Dr Richard Crawley, Dr Brian Halliday, Dr Rosita Zakeri
Landmark trials in heart failure – 30 years from CONSENSUS With 2017 marking the 30th year since the publication of CONSENSUS,1 which first reported a reduction in mortality with enalapril versus placebo in patients with advanced heart failure (HF), the BCS held a dedicated session to review the seminal clinical trials and advances in chronic heart failure management in this period. Dr Rosita Zakeri (Royal Brompton Hospital, London) reviewed this session for us and spoke to the BJC afterwards. Rosita Zakeri The era of vasodilator therapy for heart failure began in the 1990s. Professor Karl Swedberg (University of Gothenberg, Sweden) began
May 2002 Br J Cardiol 2002;9:280-6
Angiotensin II receptor antagonists in the treatment of heart failure: background to and design of the CHARM study
Simon W Dubrey
No content available
For healthcare professionals only
